BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Massive Bio Launches Revolutionary ChatGPT-Powered Chatbot Platform at ASCO 2023 to Simplify and Expand Access to Oncology Clinical Trials

  Massive Bio, is set to showcase its groundbreaking GPT4 AI chatbots - AskFiona AI and DrArturo AI at ASCO 2023.

  June 1, 2023

   · 

  4 min read
• Biotech Bay

  CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress

  CareDx, Inc. announced a leading presence at the 2023 American Transplant Congress with 65 scientific presentations.

  June 1, 2023

   · 

  6 min read
• Pharm Country

  Laxxon Medical to Participate in 2023 BIO International Convention

  Laxxon Medical announced today its participation in the 2023 BIO International Convention.

  June 1, 2023

   · 

  1 min read
• BioMidwest

  Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes

  Panbela Therapeutics, Inc announces a poster presentation highlighting the results for CPP-1X (also known as α-Difluoromethylornithine (DFMO) or Eflornithine) in recent onset type 1 diabetes at the Immunology of Diabetes Society (IDS) meeting, which was held May 23-27, 2023.

  June 1, 2023

   · 

  8 min read
• Pharm Country

  LAVA Therapeutics to Participate in the Jefferies Healthcare Conference

  LAVA Therapeutics N.V. today announced that Stephen Hurly, president and chief executive officer of LAVA Therapeutics, will participate in a fireside chat at the Jefferies Healthcare Conference.

  June 1, 2023

   · 

  1 min read
• Genetown

  Artax Biopharma Announces Positive Phase 1 Results for AX-158, Company’s First-in-Class Oral Immunomodulator Developed to Treat T Cell-Mediated Diseases

  Artax Biopharma, Inc. today announces positive Phase 1 clinical trial results for AX-158, the Company’s first-in-class oral small molecule immunomodulator to enter clinical development to treat T Cell-mediated diseases.

  June 1, 2023

   · 

  4 min read
• Business

  National Kidney Foundation Appoints Walmart Chief Medical Officer Dr. Wigneswaran to National Board of Directors

  The National Kidney Foundation is thrilled to announce the appointment of Dr. John Wigneswaran, Walmart’s Chief Medical Officer, to NKF’s National Board of Directors.

  June 1, 2023

   · 

  3 min read
• Pharm Country

  Rallybio to Present at the Jefferies Healthcare Conference

  Rallybio Corporation today announced that Company management will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9 at 9:00AM ET in New York, NY.

  June 1, 2023

   · 

  1 min read
• Biotech Beach

  Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences

  Equillium, Inc. today announced that it will present at the Jefferies Global Healthcare Conference and the LD Micro Invitational Conference.

  June 1, 2023

   · 

  4 min read
• Pharm Country

  Inspirna to Present at the Jefferies Healthcare Conference

  Inspirna, Inc. announced today that Chief Executive Officer Dr. Usman “Oz” Azam, M.D., will participate in a corporate presentation at the Jefferies Healthcare Conference on June 8, 2023 at 1:30pm ET.

  June 1, 2023

   · 

  2 min read